#1 Clinical Trials Search in Europe

Tranexamic Acid

Tranexamic acid is a medication that has been the subject of numerous clinical trials across various medical fields. These trials aim to evaluate its effectiveness in reducing blood loss and improving patient outcomes in conditions ranging from heavy menstrual bleeding to orthopedic surgeries. This article explores the use of tranexamic acid in different clinical settings and its potential benefits for patients.

Table of Contents

What is Tranexamic Acid?

Tranexamic acid (TXA) is a medication used to control bleeding in various medical situations. It is known by several other names, including Lysteda, Transamin, and Exacyl[2]. TXA is a synthetic amino acid that helps prevent excessive blood loss by promoting blood clotting[1].

How Does it Work?

Tranexamic acid works by blocking specific sites on a protein called plasminogen. This action prevents the breakdown of blood clots, which helps to reduce bleeding. In simpler terms, TXA helps your blood form stronger clots and keeps those clots from breaking down too quickly[1].

Medical Uses

Tranexamic acid is used in various medical situations to control bleeding. Some of the conditions and procedures where TXA may be beneficial include:

  • Surgical procedures: TXA is often used during surgeries to reduce blood loss. This includes:
    • Orthopedic surgeries like hip and knee replacements[3]
    • Brain tumor removal surgeries[4]
    • Facial surgeries like orthognathic (jaw) procedures[5]
    • Liposuction[6]
  • Gynecological conditions: TXA can be used to reduce heavy menstrual bleeding and during procedures like laparoscopic myomectomy (removal of uterine fibroids)[7]
  • Trauma: TXA may be used in cases of severe injury to help control bleeding[2]
  • Dental procedures: Some dental surgeries may use TXA to reduce bleeding[3]

How is it Administered?

Tranexamic acid can be given in several ways, depending on the medical situation:

  • Intravenous (IV) injection: TXA is often given through a vein, either as a single dose or as a continuous infusion during surgery[4]
  • Oral medication: For some conditions, TXA may be taken by mouth as a pill or liquid
  • Topical application: In some surgical procedures, TXA may be applied directly to the surgical site[3]
  • Mixed with other solutions: In procedures like liposuction, TXA may be added to the fluid injected into the body[6]

Effectiveness

Research has shown that tranexamic acid can be effective in reducing blood loss in various medical situations. For example:

  • In hip and knee replacement surgeries, TXA has been shown to reduce blood loss and the need for blood transfusions[2]
  • During brain tumor removal surgeries, TXA may help reduce blood loss and the risk of complications related to bleeding[4]
  • In gynecological procedures, TXA can help reduce bleeding during and after surgery[7]

Potential Side Effects

While tranexamic acid is generally considered safe, like all medications, it can have side effects. Some potential side effects include:

  • Gastrointestinal issues: Nausea, vomiting, or diarrhea[3]
  • Allergic reactions: In rare cases, some people may have an allergic reaction to TXA
  • Blood clots: There is a theoretical risk of developing blood clots, although this is rare when TXA is used as directed[3]
  • Seizures: In very rare cases, TXA has been associated with seizures[4]

It’s important to discuss any concerns about side effects with your healthcare provider.

Ongoing Research

Researchers continue to study tranexamic acid to better understand its benefits and optimal use in different medical situations. Some areas of ongoing research include:

  • Using TXA to reduce the need for lowering blood pressure during certain surgeries[5]
  • Investigating the best ways to administer TXA in different types of surgeries[6]
  • Studying the effects of TXA on reducing bruising and swelling after procedures like liposuction[6]

These ongoing studies help doctors better understand how to use tranexamic acid safely and effectively to improve patient care.

Aspect Details
Medical Conditions Studied Heavy menstrual bleeding, orthopedic surgeries, head and neck surgeries, obstetrical hemorrhage
Administration Methods Oral tablets, intravenous injections, topical application
Primary Outcomes Measured Blood loss reduction, transfusion rates, hemoglobin levels, functional outcomes
Potential Benefits Reduced blood loss, fewer transfusions, shorter hospital stays, improved recovery
Safety Considerations Monitoring for side effects and thrombotic events, generally considered safe in most studies
Ongoing Research Focus Optimal dosing, timing of administration, comparison with other treatments

FAQ

  • What is tranexamic acid? Tranexamic acid is a medication that belongs to the class of antifibrinolytic agents. It works by inhibiting the breakdown of blood clots, which helps to reduce bleeding.
  • In which medical conditions is tranexamic acid being studied? Tranexamic acid is being studied in various conditions, including heavy menstrual bleeding, orthopedic surgeries (like total knee and hip replacements), head and neck surgeries, and obstetrical hemorrhage.
  • How is tranexamic acid administered in clinical trials? Tranexamic acid can be administered in different ways depending on the study. Common methods include oral tablets, intravenous injections, and topical application directly to surgical sites.
  • What are the potential benefits of using tranexamic acid? Potential benefits include reduced blood loss, decreased need for blood transfusions, shorter hospital stays, and improved functional outcomes in some surgical procedures.
  • Are there any safety concerns with tranexamic acid use? While generally considered safe, some studies monitor for potential side effects such as nausea, vomiting, and the theoretical risk of blood clots. However, most trials have not shown a significant increase in thrombotic events.

Ongoing Clinical Trials on Tranexamic Acid

  • Tranexamic Acid versus Placebo for Reducing Infection after Mid‑and Hind‑Foot Arthrodesis in Adults with Deformity or Osteoarthritis

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on the Effect of Tranexamic Acid to Reduce Bleeding in Patients on Blood Thinners After Pacemaker Surgery

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Efficacy of Tranexamic Acid in Reducing Perioperative Blood Loss in Patients with Hip Fracture: A Randomized, Double-Blind Clinical Trial

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Pain Relief After Shoulder Surgery Using Tranexamic Acid and Sodium Chloride for Patients Undergoing Arthroscopic Procedures

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Tranexamic Acid and Sodium Chloride for Reducing Blood Loss in Patients Undergoing Burn Surgery

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Estonia +13

  • Study on Spinal vs. General Anaesthesia with Ropivacaine Hydrochloride for Osteoarthritis Patients Undergoing Hip and Knee Replacement

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Tranexamic Acid to Reduce Blood Loss in Hip Replacement Surgery for Patients with Hip Arthropathy

    Not recruiting

    2 1 1
    Investigated drugs:
    France

  • Study on Tranexamic Acid and Terlipressin for Emergency Treatment of Mild to Severe Hemoptysis in Patients Without Cystic Fibrosis

    Not recruiting

    3 1 1
    Investigated drugs:
    France

Glossary

  • Antifibrinolytic: A type of medication that helps prevent the breakdown of blood clots, thereby reducing bleeding.
  • Menorrhagia: Abnormally heavy or prolonged menstrual bleeding.
  • Thrombotic events: The formation of blood clots in blood vessels, which can potentially cause serious health issues.
  • Hemoglobin: A protein in red blood cells that carries oxygen throughout the body.
  • Hematocrit: The percentage of red blood cells in the blood, used to measure blood volume and detect anemia.
  • Pictorial Blood Loss Assessment Chart (PBAC): A tool used to estimate menstrual blood loss by visually assessing sanitary products.
  • Venous Thromboembolism (VTE): A condition where blood clots form in the veins, typically in the legs or lungs.
  • Total Knee Arthroplasty (TKA): A surgical procedure to replace the knee joint with artificial components.
  • Postpartum Hemorrhage (PPH): Excessive bleeding after childbirth, which can be a serious complication.

References

  1. https://clinicaltrials.gov/study/NCT04178655
  2. https://clinicaltrials.gov/study/NCT03019198
  3. https://clinicaltrials.gov/study/NCT01940692
  4. https://clinicaltrials.gov/study/NCT06229483
  5. https://clinicaltrials.gov/study/NCT05474027
  6. https://clinicaltrials.gov/study/NCT06648265
  7. https://clinicaltrials.gov/study/NCT04192643